Abstract:Aim To explore the mechanisms underlying the HO-1-regulated apoptosis and autophagy in human chronic myeloid leukemia (CML) K562 cell line in vitro. Methods K562 cells were devided into three groupsFK562(untreated),K562-H(infected by lenti-GFP-HO-1) and K562-siHO-1(infected by lenti-GFP-siHO-1). The protein expression of HO-1 were determined by Western blot, and its mRNA levels were obtained by real-time PCR. Cell viability was assessed by MTT assay. Morphological changes of apoptosis and autophagy were observed by the application of transmission electron microscope. Annexin V-FITC/PI dual staining assays were used to measure apoptosis. Autophagy was analyzed by Western blot and immunofluorescence staining with an anti-LC3 antibody. DCFH-DA was used as the cell-permeate indicator for intracellular ROS measurement. Protein levels of active caspase 3, Beclin1,cyto-C and Bcl2 were determined by Western blot. Results The Expression of HO-1 on mRNA and protein level increased in K562-H group while reduced in K562-siHO-1, the differences showed statistically significance compared to K562-untreated group (p<0.05). Imatinib (0.20-1.60μmol/L) exerted inhibitory effects on cell proliferation in a concentration-dependent manner with IC(50) value of 1.0μmol/L, 0.7μmol/L and 0.4μmol/L, while viability of 63.41±1.46%, 41.24±2.01%, 29.49±1.87% in K562-H, K562 and K562-siHO-1( p<0.05 ), respectively. Exposure to imatinib (0.40 μmol/L) simultaneously induced mitochondrial-mediated apoptosis and Beclin1-dependent autophagy in all groups. Autophagy flux was found in K562-siHO-1 group while autophagosome formation decreased in K562-H group, which was significantly different from K562 group. The expressions of LC3 II and cyto-C were higher in K562-siHO-1 group than other two groups ( p<0.05 ). Both apoptosis and autophagy caused cell death in a time-dependent manner. However, apoptosis played a more effective role in cell death. After exposure to imatinib (0.40 μmol/L), both intracellular ROS generation and the protein expression of Beclin1 and caspase9 were increased, while Bcl2 protein level were reduced in a time-dependent manner. The combination of NAC (2.50 mmol/L) with imatinib (0.40 μmol/L) contributed to the blockade of ROS generation which abrogated apoptosis, autophagy and Beclin1 expression. 3-MA (3.0mmol/L) and HO-1 silencing resulting in the inhibition of autophagy enhanced the effect of apoptosis which was induced by imatinib (respectively 70.65±2.71% and 69.27±3.13%), while this phenomenon was accompanied by increased ROS generation (1.3 and 1.6 folds higher than K562 group). Conclusions Imatinib and HO-1 siRNA simultaneously induced apoptosis and autophagy in K562 cells, which was associated with the increasing of intracellular ROS generation, cyto-C and Beclin1 protein expression. Beclin1, an autophagy related protein induced by HO-1 silencing, could further induce apoptosis in K562 cells through the inhibition of Bcl2. The responsive cytoprotection to chemotherapeutics caused by autophagy decreased while sustaining up-regulation of HO-1 in K562 cells. However, the underlying mechanisms remained to be well elucidated. Disclosures: No relevant conflicts of interest to declare.

Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis

Beclin 1-Mediated Macroautophagy Involves Regulation of Caspase-9 Expression in Cervical Cancer HeLa Cells

Autophagy Regulates Apoptosis by Targeting NOXA for Degradation.

Caspase-mediated cleavage of Beclin1 inhibits autophagy and promotes apoptosis induced by S1 in human ovarian cancer SKOV3 cells

Beclin 1, an Autophagy-Related Gene, Augments Apoptosis in U87 Glioblastoma Cells

Beclin 1 Bridges Autophagy, Apoptosis and Differentiation

The molecular mechanisms underlying BCR/ABL degradation in chronic myeloid leukemia cells promoted by Beclin1-mediated autophagy.

ASB3 Knockdown Promotes Mitochondrial Apoptosis Via Activating the Interdependent Cleavage of Beclin1 and Caspase-8 in Hepatocellular Carcinoma

Knockdown of Beclin-1 Impairs Epithelial-Mesenchymal Transition of Colon Cancer Cells.

Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy

Regulation of an ATG7-beclin 1 Program of Autophagic Cell Death by Caspase-8.

Beclin 1 Biology And Its Role In Heart Disease

The Pivotal Role of C-Jun Nh2-Terminal Kinase-Mediated Beclin 1 Expression During Anticancer Agents-Induced Autophagy in Cancer Cells

The Function of Bcl-2/Beclin-1 Complex in Autophagy Regulation

Caspase Cleavage of Mcl-1 Impairs Its Anti-Apoptotic Activity and Proteasomal Degradation in Non-Small Lung Cancer Cells

Beclin-1: autophagic regulator and therapeutic target in cancer.

CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression

Beclin 1 functions as a negative modulator of MLKL oligomerisation by integrating into the necrosome complex

Caspases: a Molecular Switch Node in the Crosstalk Between Autophagy and Apoptosis.

Molecular mechanisms underlying the BIRC6-mediated regulation of apoptosis and autophagy

Ho-1 Regulated Autophagy and Apoptosis in Cml Cells Through Mitochondrial-Beclin1 Pathway